Diverticulitis Treatment Market, Global Outlook and Forecast 2023-2029

Report ID: MMG194258 | Category: Medical Devices & Consumables | Pages: 103 | Format: PDF | Published Date: September 04,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

Diverticular disease and diverticulitis are related digestive conditions that affect the large intestine (colon). In diverticular disease, small bulges or pockets (diverticula) develop in the lining of the intestine. Diverticulitis is when these pockets become inflamed or infected.
This report aims to provide a comprehensive presentation of the global market for Diverticulitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diverticulitis Treatment. This report contains market size and forecasts of Diverticulitis Treatment in global, including the following market information:
Global Diverticulitis Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Diverticulitis Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Drug Treatment Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Diverticulitis Treatment include Pfizer, G.D. Searle LLC, Teva Pharmaceutical Industries Ltd, Abbott Laboratories, B. Braun Medical Inc, GSK plc, Bayer HealthCare Pharmaceuticals Inc, Roche Holding AG and Johnson & Johnson Services, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diverticulitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diverticulitis Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Diverticulitis Treatment Market Segment Percentages, by Type, 2022 (%)
    Drug Treatment
    Surgical Treatment
    Supportive Care
    Others
Global Diverticulitis Treatment Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Diverticulitis Treatment Market Segment Percentages, by Application, 2022 (%)
    Hospitals
    Clinics
    Diagnostic Centers
    Ambulatory Surgical Center
    Others
Global Diverticulitis Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Diverticulitis Treatment Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diverticulitis Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Diverticulitis Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Pfizer
    G.D. Searle LLC
    Teva Pharmaceutical Industries Ltd
    Abbott Laboratories
    B. Braun Medical Inc
    GSK plc
    Bayer HealthCare Pharmaceuticals Inc
    Roche Holding AG
    Johnson & Johnson Services
    Sucampo Pharmaceuticals Inc
    Valeant Pharmaceuticals International Inc
    Synergy Pharmaceuticals Inc
    Ardelyx Inc
    Astellas Pharma Inc
    Novartis AG
    Hikma Pharmaceuticals
    Baxter International
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diverticulitis Treatment, market overview.
Chapter 2: Global Diverticulitis Treatment market size in revenue.
Chapter 3: Detailed analysis of Diverticulitis Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diverticulitis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Diverticulitis Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Diverticulitis Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Diverticulitis Treatment Overall Market Size
    2.1 Global Diverticulitis Treatment Market Size: 2022 VS 2029
    2.2 Global Diverticulitis Treatment Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Diverticulitis Treatment Players in Global Market
    3.2 Top Global Diverticulitis Treatment Companies Ranked by Revenue
    3.3 Global Diverticulitis Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Diverticulitis Treatment Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Diverticulitis Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Diverticulitis Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Diverticulitis Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Diverticulitis Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Diverticulitis Treatment Market Size Markets, 2022 & 2029
        4.1.2 Drug Treatment
        4.1.3 Surgical Treatment
        4.1.4 Supportive Care
        4.1.5 Others
    4.2 By Type - Global Diverticulitis Treatment Revenue & Forecasts
        4.2.1 By Type - Global Diverticulitis Treatment Revenue, 2018-2023
        4.2.2 By Type - Global Diverticulitis Treatment Revenue, 2024-2029
        4.2.3 By Type - Global Diverticulitis Treatment Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Diverticulitis Treatment Market Size, 2022 & 2029
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Diagnostic Centers
        5.1.5 Ambulatory Surgical Center
        5.1.6 Others
    5.2 By Application - Global Diverticulitis Treatment Revenue & Forecasts
        5.2.1 By Application - Global Diverticulitis Treatment Revenue, 2018-2023
        5.2.2 By Application - Global Diverticulitis Treatment Revenue, 2024-2029
        5.2.3 By Application - Global Diverticulitis Treatment Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Diverticulitis Treatment Market Size, 2022 & 2029
    6.2 By Region - Global Diverticulitis Treatment Revenue & Forecasts
        6.2.1 By Region - Global Diverticulitis Treatment Revenue, 2018-2023
        6.2.2 By Region - Global Diverticulitis Treatment Revenue, 2024-2029
        6.2.3 By Region - Global Diverticulitis Treatment Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Diverticulitis Treatment Revenue, 2018-2029
        6.3.2 US Diverticulitis Treatment Market Size, 2018-2029
        6.3.3 Canada Diverticulitis Treatment Market Size, 2018-2029
        6.3.4 Mexico Diverticulitis Treatment Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Diverticulitis Treatment Revenue, 2018-2029
        6.4.2 Germany Diverticulitis Treatment Market Size, 2018-2029
        6.4.3 France Diverticulitis Treatment Market Size, 2018-2029
        6.4.4 U.K. Diverticulitis Treatment Market Size, 2018-2029
        6.4.5 Italy Diverticulitis Treatment Market Size, 2018-2029
        6.4.6 Russia Diverticulitis Treatment Market Size, 2018-2029
        6.4.7 Nordic Countries Diverticulitis Treatment Market Size, 2018-2029
        6.4.8 Benelux Diverticulitis Treatment Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Diverticulitis Treatment Revenue, 2018-2029
        6.5.2 China Diverticulitis Treatment Market Size, 2018-2029
        6.5.3 Japan Diverticulitis Treatment Market Size, 2018-2029
        6.5.4 South Korea Diverticulitis Treatment Market Size, 2018-2029
        6.5.5 Southeast Asia Diverticulitis Treatment Market Size, 2018-2029
        6.5.6 India Diverticulitis Treatment Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Diverticulitis Treatment Revenue, 2018-2029
        6.6.2 Brazil Diverticulitis Treatment Market Size, 2018-2029
        6.6.3 Argentina Diverticulitis Treatment Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Diverticulitis Treatment Revenue, 2018-2029
        6.7.2 Turkey Diverticulitis Treatment Market Size, 2018-2029
        6.7.3 Israel Diverticulitis Treatment Market Size, 2018-2029
        6.7.4 Saudi Arabia Diverticulitis Treatment Market Size, 2018-2029
        6.7.5 UAE Diverticulitis Treatment Market Size, 2018-2029
7 Diverticulitis Treatment Companies Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Diverticulitis Treatment Major Product Offerings
        7.1.4 Pfizer Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.1.5 Pfizer Key News & Latest Developments
    7.2 G.D. Searle LLC
        7.2.1 G.D. Searle LLC Company Summary
        7.2.2 G.D. Searle LLC Business Overview
        7.2.3 G.D. Searle LLC Diverticulitis Treatment Major Product Offerings
        7.2.4 G.D. Searle LLC Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.2.5 G.D. Searle LLC Key News & Latest Developments
    7.3 Teva Pharmaceutical Industries Ltd
        7.3.1 Teva Pharmaceutical Industries Ltd Company Summary
        7.3.2 Teva Pharmaceutical Industries Ltd Business Overview
        7.3.3 Teva Pharmaceutical Industries Ltd Diverticulitis Treatment Major Product Offerings
        7.3.4 Teva Pharmaceutical Industries Ltd Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.3.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
    7.4 Abbott Laboratories
        7.4.1 Abbott Laboratories Company Summary
        7.4.2 Abbott Laboratories Business Overview
        7.4.3 Abbott Laboratories Diverticulitis Treatment Major Product Offerings
        7.4.4 Abbott Laboratories Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.4.5 Abbott Laboratories Key News & Latest Developments
    7.5 B. Braun Medical Inc
        7.5.1 B. Braun Medical Inc Company Summary
        7.5.2 B. Braun Medical Inc Business Overview
        7.5.3 B. Braun Medical Inc Diverticulitis Treatment Major Product Offerings
        7.5.4 B. Braun Medical Inc Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.5.5 B. Braun Medical Inc Key News & Latest Developments
    7.6 GSK plc
        7.6.1 GSK plc Company Summary
        7.6.2 GSK plc Business Overview
        7.6.3 GSK plc Diverticulitis Treatment Major Product Offerings
        7.6.4 GSK plc Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.6.5 GSK plc Key News & Latest Developments
    7.7 Bayer HealthCare Pharmaceuticals Inc
        7.7.1 Bayer HealthCare Pharmaceuticals Inc Company Summary
        7.7.2 Bayer HealthCare Pharmaceuticals Inc Business Overview
        7.7.3 Bayer HealthCare Pharmaceuticals Inc Diverticulitis Treatment Major Product Offerings
        7.7.4 Bayer HealthCare Pharmaceuticals Inc Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.7.5 Bayer HealthCare Pharmaceuticals Inc Key News & Latest Developments
    7.8 Roche Holding AG
        7.8.1 Roche Holding AG Company Summary
        7.8.2 Roche Holding AG Business Overview
        7.8.3 Roche Holding AG Diverticulitis Treatment Major Product Offerings
        7.8.4 Roche Holding AG Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.8.5 Roche Holding AG Key News & Latest Developments
    7.9 Johnson & Johnson Services
        7.9.1 Johnson & Johnson Services Company Summary
        7.9.2 Johnson & Johnson Services Business Overview
        7.9.3 Johnson & Johnson Services Diverticulitis Treatment Major Product Offerings
        7.9.4 Johnson & Johnson Services Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.9.5 Johnson & Johnson Services Key News & Latest Developments
    7.10 Sucampo Pharmaceuticals Inc
        7.10.1 Sucampo Pharmaceuticals Inc Company Summary
        7.10.2 Sucampo Pharmaceuticals Inc Business Overview
        7.10.3 Sucampo Pharmaceuticals Inc Diverticulitis Treatment Major Product Offerings
        7.10.4 Sucampo Pharmaceuticals Inc Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.10.5 Sucampo Pharmaceuticals Inc Key News & Latest Developments
    7.11 Valeant Pharmaceuticals International Inc
        7.11.1 Valeant Pharmaceuticals International Inc Company Summary
        7.11.2 Valeant Pharmaceuticals International Inc Business Overview
        7.11.3 Valeant Pharmaceuticals International Inc Diverticulitis Treatment Major Product Offerings
        7.11.4 Valeant Pharmaceuticals International Inc Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.11.5 Valeant Pharmaceuticals International Inc Key News & Latest Developments
    7.12 Synergy Pharmaceuticals Inc
        7.12.1 Synergy Pharmaceuticals Inc Company Summary
        7.12.2 Synergy Pharmaceuticals Inc Business Overview
        7.12.3 Synergy Pharmaceuticals Inc Diverticulitis Treatment Major Product Offerings
        7.12.4 Synergy Pharmaceuticals Inc Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.12.5 Synergy Pharmaceuticals Inc Key News & Latest Developments
    7.13 Ardelyx Inc
        7.13.1 Ardelyx Inc Company Summary
        7.13.2 Ardelyx Inc Business Overview
        7.13.3 Ardelyx Inc Diverticulitis Treatment Major Product Offerings
        7.13.4 Ardelyx Inc Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.13.5 Ardelyx Inc Key News & Latest Developments
    7.14 Astellas Pharma Inc
        7.14.1 Astellas Pharma Inc Company Summary
        7.14.2 Astellas Pharma Inc Business Overview
        7.14.3 Astellas Pharma Inc Diverticulitis Treatment Major Product Offerings
        7.14.4 Astellas Pharma Inc Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.14.5 Astellas Pharma Inc Key News & Latest Developments
    7.15 Novartis AG
        7.15.1 Novartis AG Company Summary
        7.15.2 Novartis AG Business Overview
        7.15.3 Novartis AG Diverticulitis Treatment Major Product Offerings
        7.15.4 Novartis AG Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.15.5 Novartis AG Key News & Latest Developments
    7.16 Hikma Pharmaceuticals
        7.16.1 Hikma Pharmaceuticals Company Summary
        7.16.2 Hikma Pharmaceuticals Business Overview
        7.16.3 Hikma Pharmaceuticals Diverticulitis Treatment Major Product Offerings
        7.16.4 Hikma Pharmaceuticals Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.16.5 Hikma Pharmaceuticals Key News & Latest Developments
    7.17 Baxter International
        7.17.1 Baxter International Company Summary
        7.17.2 Baxter International Business Overview
        7.17.3 Baxter International Diverticulitis Treatment Major Product Offerings
        7.17.4 Baxter International Diverticulitis Treatment Revenue in Global Market (2018-2023)
        7.17.5 Baxter International Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Diverticulitis Treatment Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?